Evidence map›Paper›PMID 24286950›Full record

ReviewEndocrinology and metabolism clinics of North America2013

Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Ankur Jindal, Mariana Garcia-Touza, Nidhi Jindal, Adam Whaley-Connell, James R Sowers

Open access · greenAbstract readReview
In one paragraph

Review in Endocrinology and metabolism clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Ginsenoside Rg1 Alleviates Podocyte EMT Passage by Regulating AKT/GSK3Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  7. Article
  8. Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.Endocrinology and metabolism clinics of North America · 2018
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Perioperative management of diabetic foot.Frontiers in pharmacology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ankur JindalHospital Medicine, Department of Internal Medicine, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA; Diabetes and Cardiovascular Research Center, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA.
Mariana Garcia-Touza
Nidhi Jindal
Adam Whaley-Connell
James R Sowers
Harry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri Hospital · USUniversity of Missouri · US

Funding

ANG II OPPOSES INS MEDIATED VASORELAXATION &GLU UTILZAR01HL073101 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SOWERS, JAMES RUSSELL · 2004 to 2013
$2.7M
Ang II and Overnutrition and Insulin resistance in Cardiovascular TissueR01HL107910 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI SOWERS, JAMES RUSSELL · 2011 to 2015
$1.8M
The Role of Angiotensin II on mTOR mediated Tubulointerstitial FibrosisR03AG040638 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI WHALEY CONNELL, ADAM T · 2011 to 2012
$146k
Interactions of the RAAS and a Western Diet on Insulin Metabolic ActionsI01BX001981 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI LASTRA, GUIDO · 2013 to 2022
–
NHLBI NIH HHS R01 HL073101NHLBI NIH HHS R01 HL107910NHLBI NIH HHS R01 HL107910-01NHLBI NIH HHS R01 HL73101-01A1NIA NIH HHS R-03 AG040638NIA NIH HHS R03 AG040638
6 · The paper itself

Abstract

In this article, the literature is reviewed regarding the role of blood pressure variability and nocturnal nondipping of blood pressure as well as the presence of diabetic kidney disease (DKD), in the absence of albuminuria, as risk predictors for progressive DKD. The importance of glycemic and blood pressure control in patients with diabetes and chronic kidney disease, and the use of oral hypoglycemic agents and antihypertensive agents in this patient cohort, are also discussed.

Indexed as

Angiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBiomarkersBlood GlucoseBlood PressureCardio-Renal SyndromeDiabetic NephropathiesHomeostasisHumansHypertension, RenalHypoglycemic AgentsPrognosisRisk FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBiomarkersBlood GlucoseHypoglycemic AgentsAlbuminuriaBlood pressure variabilityCardiorenal syndromeChronic kidney diseaseDiabetesDiabetic nephropathyProteinuria

Identifiers

PMID24286950
PMCPMC4251585
OpenAlexW1844617455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.